These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 29290656)
1. Early gastric cancer frequently has high expression of KK-LC-1, a cancer-testis antigen. Futawatari N; Fukuyama T; Yamamura R; Shida A; Takahashi Y; Nishi Y; Ichiki Y; Kobayashi N; Yamazaki H; Watanabe M World J Gastroenterol; 2017 Dec; 23(46):8200-8206. PubMed ID: 29290656 [TBL] [Abstract][Full Text] [Related]
2. Correlation Between Expression of the Cancer/Testis Antigen KK-LC-1 and Fukuyama T; Futawatari N; Ichiki Y; Shida A; Yamazaki T; Nishi Y; Nonoguchi H; Takahashi Y; Yamazaki H; Kobayashi N In Vivo; 2017; 31(3):403-407. PubMed ID: 28438869 [TBL] [Abstract][Full Text] [Related]
3. Frequent High Expression of Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1) in Gastric Cancer. Shida A; Futawatari N; Fukuyama T; Ichiki Y; Takahashi Y; Nishi Y; Kobayashi N; Yamazaki H; Watanabe M Anticancer Res; 2015 Jun; 35(6):3575-9. PubMed ID: 26026129 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer. Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M Tumori; 2014; 100(1):60-8. PubMed ID: 24675493 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer. Shigematsu Y; Hanagiri T; Shiota H; Kuroda K; Baba T; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Takenoyama M; Yasumoto K Lung Cancer; 2010 Apr; 68(1):105-10. PubMed ID: 19545928 [TBL] [Abstract][Full Text] [Related]
6. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features. Grah J; Samija M; Juretić A; Sarcević B; Sobat H Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744 [TBL] [Abstract][Full Text] [Related]
7. Demethylation of MAGE promoters during gastric cancer progression. Honda T; Tamura G; Waki T; Kawata S; Terashima M; Nishizuka S; Motoyama T Br J Cancer; 2004 Feb; 90(4):838-43. PubMed ID: 14970862 [TBL] [Abstract][Full Text] [Related]
8. Expression of cancer-testis antigens MAGE-A3/6 and NY-ESO-1 in non-small-cell lung carcinomas and their relationship with immune cell infiltration. Kim SH; Lee S; Lee CH; Lee MK; Kim YD; Shin DH; Choi KU; Kim JY; Park DY; Sol MY Lung; 2009; 187(6):401-11. PubMed ID: 19795170 [TBL] [Abstract][Full Text] [Related]
9. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer. Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258 [TBL] [Abstract][Full Text] [Related]
10. The role of the NY-ESO-1 in the prognosis of gastric cancer. Misir Z; Glavčić G; Janković S; Kruljac I; Čugura Filipović J; Čimić K; Ulamec M Biomol Biomed; 2023 Dec; 24(4):813-820. PubMed ID: 38153439 [TBL] [Abstract][Full Text] [Related]
11. Expression of MAGE-A and NY-ESO-1 in Primary and Metastatic Cancers. Park TS; Groh EM; Patel K; Kerkar SP; Lee CC; Rosenberg SA J Immunother; 2016 Jan; 39(1):1-7. PubMed ID: 26641256 [TBL] [Abstract][Full Text] [Related]
12. Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma. Gjerstorff MF; Pøhl M; Olsen KE; Ditzel HJ BMC Cancer; 2013 Oct; 13():466. PubMed ID: 24103781 [TBL] [Abstract][Full Text] [Related]
13. Expression and clinical significance of MAGE and NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head and neck. Veit JA; Heine D; Thierauf J; Lennerz J; Shetty S; Schuler PJ; Whiteside T; Beutner D; Meyer M; Grünewald I; Ritter G; Gnjatic S; Sikora AG; Hoffmann TK; Laban S Head Neck; 2016 Jul; 38(7):1008-16. PubMed ID: 26874246 [TBL] [Abstract][Full Text] [Related]
14. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer. Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423 [TBL] [Abstract][Full Text] [Related]
15. KK-LC-1 may be an effective prognostic biomarker for gastric cancer. Ji J; Chen J; Wang A; Zhang W; Ju H; Liu Y; Li L BMC Cancer; 2021 Mar; 21(1):267. PubMed ID: 33711953 [TBL] [Abstract][Full Text] [Related]
16. Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy? Tessari A; Pilla L; Silvia D; Duca M; Paolini B; Carcangiu ML; Mariani L; de Braud FG; Cresta S Breast; 2018 Dec; 42():68-73. PubMed ID: 30189381 [TBL] [Abstract][Full Text] [Related]
17. Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma. Wang M; Li J; Wang L; Chen X; Zhang Z; Yue D; Ping Y; Shi X; Huang L; Zhang T; Yang L; Zhao Y; Ma X; Li D; Fan Z; Zhao L; Tang Z; Zhai W; Zhang B; Zhang Y Int J Clin Exp Pathol; 2015; 8(4):3513-28. PubMed ID: 26097535 [TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic significance of cancer-testis antigens (CTA) in intrahepatic cholagiocarcinoma. Zhou JX; Li Y; Chen SX; Deng AM J Exp Clin Cancer Res; 2011 Jan; 30(1):2. PubMed ID: 21211023 [TBL] [Abstract][Full Text] [Related]
19. MAGE-A3/4 and NY-ESO-1 antigens expression in metastatic esophageal squamous cell carcinoma. Bujas T; Marusic Z; Peric Balja M; Mijic A; Kruslin B; Tomas D Eur J Histochem; 2011 Mar; 55(1):e7. PubMed ID: 21556122 [TBL] [Abstract][Full Text] [Related]
20. Expression of the tumor antigens NY-ESO-1, tyrosinase, MAGE-A3, and TPTE in pediatric and adult melanoma: a retrospective case control study. Forchhammer S; Pop OT; Hahn M; Aebischer V; Seitz CM; Schroeder C; Liebmann A; Abele M; Wild H; Bien E; Kunc M; Schneider DT; Cuk K; Büttel I; Flemmig C; Peters M; Laible M; Brück P; Türeci Ö; Sahin U; Flatz L; Brecht IB Virchows Arch; 2024 Aug; 485(2):335-346. PubMed ID: 38890171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]